Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

Source:http://linkedlifedata.com/resource/pubmed/id/17440161

J. Natl. Cancer Inst. 2007 Apr 18 99 8 601-7

Download in:

View as

Triples

General Info

PMID
17440161